25 XP   0   0   10

Arcadia Biosciences Inc
Buy, Hold or Sell?

Let's analyse Arcadia Biosciences Inc together

PenkeI guess you are interested in Arcadia Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Arcadia Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Arcadia Biosciences Inc

I send you an email if I find something interesting about Arcadia Biosciences Inc.

Quick analysis of Arcadia Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Arcadia Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$9.88
Expected worth in 1 year
$0.94
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-8.94
Return On Investment
-458.4%

For what price can you sell your share?

Current Price per Share
$1.95
Expected price per share
$0 - $2.34
How sure are you?
50%

1. Valuation of Arcadia Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$1.95

Intrinsic Value Per Share

$-227.63 - $-144.96

Total Value Per Share

$-217.74 - $-135.08

2. Growth of Arcadia Biosciences Inc (5 min.)




Is Arcadia Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.7m$25.7m-$10.1m-64.6%

How much money is Arcadia Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$3.8m$1.7m83.0%
Net Profit Margin-150.1%-205.7%--

How much money comes from the company's main activities?

3. Financial Health of Arcadia Biosciences Inc (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  

What can you expect buying and holding a share of Arcadia Biosciences Inc? (5 min.)

Welcome investor! Arcadia Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Arcadia Biosciences Inc.

What can you expect buying and holding a share of Arcadia Biosciences Inc?

First you should know what it really means to hold a share of Arcadia Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Arcadia Biosciences Inc is $1.9501. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Arcadia Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Arcadia Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.88. Based on the TTM, the Book Value Change Per Share is $-2.24 per quarter. Based on the YOY, the Book Value Change Per Share is $4.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Arcadia Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.22-113.8%-2.99-153.2%-4.62-236.9%-2.97-152.3%-3.60-184.6%
Usd Book Value Change Per Share-1.44-74.0%-2.24-114.6%4.35223.3%0.3618.5%0.5126.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%44.692,291.6%22.351,146.3%
Usd Total Gains Per Share-1.44-74.0%-2.24-114.6%4.35223.3%45.052,310.1%22.861,172.5%
Usd Price Per Share3.13-4.46-0.80-3.10-3.13-
Price to Earnings Ratio-0.35-0.15--0.05--0.10--0.25-
Price-to-Total Gains Ratio-2.17--2.01--0.17--0.35--0.48-
Price to Book Ratio0.32-0.35-0.03-0.67-1.42-
Price-to-Total Gains Ratio-2.17--2.01--0.17--0.35--0.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.9501
Number of shares512
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.0044.69
Usd Book Value Change Per Share-2.240.36
Usd Total Gains Per Share-2.2445.05
Gains per Quarter (512 shares)-1,144.3323,065.19
Gains per Year (512 shares)-4,577.3192,260.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4577-45879152373792251
20-9155-91641830471475184512
30-13732-137412745702212276773
40-18309-183183660942949369034
50-22887-228954576173686461295
60-27464-274725491414424553556
70-32041-320496406645161645817
80-36618-366267321885898738078
90-41196-412038237116636830339
100-45773-457809152357373922600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%6.034.00.015.0%6.036.01.014.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%6.013.01.030.0%11.028.01.027.5%12.030.01.027.9%
Dividend per Share0.00.04.00.0%2.00.010.016.7%3.00.017.015.0%5.00.035.012.5%5.00.038.011.6%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%7.012.01.035.0%12.027.01.030.0%13.029.01.030.2%

Fundamentals of Arcadia Biosciences Inc

About Arcadia Biosciences Inc

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Fundamental data was last updated by Penke on 2024-04-12 16:44:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Arcadia Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Arcadia Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • A Net Profit Margin of -243.8% means that $-2.44 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Arcadia Biosciences Inc:

  • The MRQ is -243.8%. The company is making a huge loss. -2
  • The TTM is -150.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-243.8%TTM-150.1%-93.7%
TTM-150.1%YOY-205.7%+55.6%
TTM-150.1%5Y-489.4%+339.3%
5Y-489.4%10Y-561.2%+71.8%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-243.8%3.0%-246.8%
TTM-150.1%2.9%-153.0%
YOY-205.7%3.0%-208.7%
5Y-489.4%3.4%-492.8%
10Y-561.2%3.6%-564.8%
1.1.2. Return on Assets

Shows how efficient Arcadia Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • -14.5% Return on Assets means that Arcadia Biosciences Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Arcadia Biosciences Inc:

  • The MRQ is -14.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.5%TTM-8.8%-5.7%
TTM-8.8%YOY-11.4%+2.7%
TTM-8.8%5Y-8.6%-0.2%
5Y-8.6%10Y-11.2%+2.7%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.5%1.4%-15.9%
TTM-8.8%1.4%-10.2%
YOY-11.4%1.4%-12.8%
5Y-8.6%1.5%-10.1%
10Y-11.2%1.7%-12.9%
1.1.3. Return on Equity

Shows how efficient Arcadia Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • -22.2% Return on Equity means Arcadia Biosciences Inc generated $-0.22 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Arcadia Biosciences Inc:

  • The MRQ is -22.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.2%TTM-14.3%-8.0%
TTM-14.3%YOY-15.2%+1.0%
TTM-14.3%5Y-19.1%+4.9%
5Y-19.1%10Y-58.5%+39.4%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.2%3.0%-25.2%
TTM-14.3%2.9%-17.2%
YOY-15.2%3.1%-18.3%
5Y-19.1%3.0%-22.1%
10Y-58.5%3.2%-61.7%

1.2. Operating Efficiency of Arcadia Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Arcadia Biosciences Inc is operating .

  • Measures how much profit Arcadia Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • An Operating Margin of -278.2% means the company generated $-2.78  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Arcadia Biosciences Inc:

  • The MRQ is -278.2%. The company is operating very inefficient. -2
  • The TTM is -336.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-278.2%TTM-336.7%+58.5%
TTM-336.7%YOY-272.1%-64.6%
TTM-336.7%5Y-1,102.3%+765.6%
5Y-1,102.3%10Y-810.9%-291.5%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-278.2%5.0%-283.2%
TTM-336.7%3.6%-340.3%
YOY-272.1%4.9%-277.0%
5Y-1,102.3%5.2%-1,107.5%
10Y-810.9%5.1%-816.0%
1.2.2. Operating Ratio

Measures how efficient Arcadia Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 3.78 means that the operating costs are $3.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Arcadia Biosciences Inc:

  • The MRQ is 3.782. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.562. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.782TTM3.562+0.220
TTM3.562YOY3.608-0.046
TTM3.5625Y9.458-5.896
5Y9.45810Y8.063+1.395
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7821.551+2.231
TTM3.5621.515+2.047
YOY3.6081.455+2.153
5Y9.4581.394+8.064
10Y8.0631.257+6.806

1.3. Liquidity of Arcadia Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Arcadia Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 4.17 means the company has $4.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Arcadia Biosciences Inc:

  • The MRQ is 4.170. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.416. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.170TTM5.416-1.246
TTM5.416YOY6.585-1.168
TTM5.4165Y5.831-0.414
5Y5.83110Y6.838-1.007
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1701.561+2.609
TTM5.4161.607+3.809
YOY6.5851.604+4.981
5Y5.8311.638+4.193
10Y6.8381.630+5.208
1.3.2. Quick Ratio

Measures if Arcadia Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • A Quick Ratio of 4.81 means the company can pay off $4.81 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Arcadia Biosciences Inc:

  • The MRQ is 4.813. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.497. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.813TTM5.497-0.683
TTM5.497YOY5.616-0.120
TTM5.4975Y5.925-0.428
5Y5.92510Y8.846-2.921
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8130.554+4.259
TTM5.4970.566+4.931
YOY5.6160.612+5.004
5Y5.9250.704+5.221
10Y8.8460.728+8.118

1.4. Solvency of Arcadia Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Arcadia Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Arcadia Biosciences Inc to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.36 means that Arcadia Biosciences Inc assets are financed with 35.5% credit (debt) and the remaining percentage (100% - 35.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Arcadia Biosciences Inc:

  • The MRQ is 0.355. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.372. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.355TTM0.372-0.017
TTM0.372YOY0.252+0.120
TTM0.3725Y0.433-0.061
5Y0.43310Y0.607-0.173
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3550.484-0.129
TTM0.3720.488-0.116
YOY0.2520.481-0.229
5Y0.4330.483-0.050
10Y0.6070.492+0.115
1.4.2. Debt to Equity Ratio

Measures if Arcadia Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 54.5% means that company has $0.55 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Arcadia Biosciences Inc:

  • The MRQ is 0.545. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.597. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.545TTM0.597-0.052
TTM0.597YOY0.337+0.260
TTM0.5975Y1.004-0.407
5Y1.00410Y1.873-0.870
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5450.950-0.405
TTM0.5970.955-0.358
YOY0.3370.939-0.602
5Y1.0040.995+0.009
10Y1.8731.074+0.799

2. Market Valuation of Arcadia Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Arcadia Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Arcadia Biosciences Inc to the Packaged Foods industry mean.
  • A PE ratio of -0.35 means the investor is paying $-0.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Arcadia Biosciences Inc:

  • The EOD is -0.220. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.353. Based on the earnings, the company is expensive. -2
  • The TTM is 0.146. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.220MRQ-0.353+0.133
MRQ-0.353TTM0.146-0.499
TTM0.146YOY-0.055+0.201
TTM0.1465Y-0.096+0.242
5Y-0.09610Y-0.248+0.152
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-0.22013.623-13.843
MRQ-0.35312.534-12.887
TTM0.14613.933-13.787
YOY-0.05512.854-12.909
5Y-0.09616.330-16.426
10Y-0.24819.210-19.458
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Arcadia Biosciences Inc:

  • The EOD is -0.151. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.243. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.377. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.151MRQ-0.243+0.091
MRQ-0.243TTM-0.377+0.135
TTM-0.377YOY-0.059-0.318
TTM-0.3775Y-0.488+0.110
5Y-0.48810Y-0.402-0.086
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1513.218-3.369
MRQ-0.2433.087-3.330
TTM-0.3771.634-2.011
YOY-0.0590.370-0.429
5Y-0.4881.347-1.835
10Y-0.4021.376-1.778
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Arcadia Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 0.32 means the investor is paying $0.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Arcadia Biosciences Inc:

  • The EOD is 0.197. Based on the equity, the company is cheap. +2
  • The MRQ is 0.317. Based on the equity, the company is cheap. +2
  • The TTM is 0.352. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.197MRQ0.317-0.119
MRQ0.317TTM0.352-0.035
TTM0.352YOY0.033+0.319
TTM0.3525Y0.667-0.316
5Y0.66710Y1.424-0.756
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD0.1971.413-1.216
MRQ0.3171.461-1.144
TTM0.3521.443-1.091
YOY0.0331.762-1.729
5Y0.6671.856-1.189
10Y1.4242.419-0.995
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Arcadia Biosciences Inc.

3.1. Institutions holding Arcadia Biosciences Inc

Institutions are holding 25.204% of the shares of Arcadia Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Sabby Management LLC8.76360.30459730564600197.5233
2023-12-31Vanguard Group Inc1.2643014038140380
2023-12-31State Street Corporation1.093901214600
2023-12-31Virtu Financial LLC1.0240.002711370113700
2023-12-31Tower Research Capital LLC0.25940.0001288056824.5675
2023-12-31JPMorgan Chase & Co0.045805085080
2023-12-31Morgan Stanley - Brokerage Accounts0.0186020700
2023-12-31BlackRock Inc0.003403800
2023-12-31Group One Trading, LP0.001601800
2023-12-31Wells Fargo & Co0.000809112.5
2023-12-31U.S. Bancorp0.00050500
2023-12-31OLIVER LAGORE VANVALIN INVESTMENT GROUP0.00040400
2023-12-31Royal Bank of Canada0.00020200
2023-12-31HARBOUR INVESTMENTS, INC.0.00010100
2023-09-30UBS Group AG000-5010-100
Total 12.47660.3073138531+86075+62.1%

3.2. Funds holding Arcadia Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.030101403800
2024-02-29Fidelity Extended Market Index0.4390598300
2024-03-31State St US Extended Mkt Indx NL Cl C0.06660.000190800
2023-12-31SSgA U.S. Extended Market Index Class I0.06660.000190800
2024-02-29Fidelity Series Total Market Index0.0511069700
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0307041900
2023-12-31Northern Trust Extended Eq Market Idx0.0307041900
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0205028000
2024-02-29Fidelity Total Market Index0.02027300
2023-12-31SSgA U.S. Total Market Index Strategy0.01920262-6-2.2388
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0165022500
2024-02-29Spartan Total Market Index Pool E0.0157021400
2024-02-29Fidelity Nasdaq Composite Index0.006809300
2024-02-29State St US Ttl Mkt Indx SL Cl I0.004606300
2023-09-30BlackRock Extended Mkt Composite0.002803800
2023-12-31Northern Trust Wilshire 50000.001602200
2023-12-31NT US Market Cap Idx Fd - L0.001602200
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00070900
Total 1.82480.000224873-60.0%

3.3. Insider Transactions

Insiders are holding 3.189% of the shares of Arcadia Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-01Thomas J SchaeferBUY7002.06
2023-08-04Thomas J SchaeferBUY6493.67
2023-05-30Stanley Jacot JrBUY50004.31

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Arcadia Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.443-2.235+55%4.354-133%0.360-501%0.511-382%
Book Value Per Share--9.88312.324-20%23.175-57%15.995-38%14.543-32%
Current Ratio--4.1705.416-23%6.585-37%5.831-28%6.838-39%
Debt To Asset Ratio--0.3550.372-5%0.252+41%0.433-18%0.607-41%
Debt To Equity Ratio--0.5450.597-9%0.337+62%1.004-46%1.873-71%
Dividend Per Share----0%-0%44.689-100%22.353-100%
Eps---2.220-2.988+35%-4.619+108%-2.970+34%-3.601+62%
Free Cash Flow Per Share---3.225-3.001-7%-3.163-2%-3.804+18%-3.446+7%
Free Cash Flow To Equity Per Share---3.22513.838-123%-1.128-65%2.567-226%1.614-300%
Gross Profit Margin--1.0001.0000%1.0000%0.989+1%0.994+1%
Intrinsic Value_10Y_max---144.964--------
Intrinsic Value_10Y_min---227.625--------
Intrinsic Value_1Y_max---13.912--------
Intrinsic Value_1Y_min---15.899--------
Intrinsic Value_3Y_max---42.269--------
Intrinsic Value_3Y_min---54.039--------
Intrinsic Value_5Y_max---71.190--------
Intrinsic Value_5Y_min---98.756--------
Market Cap2165274.034-86%4023104.8105535569.765-27%888771.653+353%9232061.048-56%6686118.810-40%
Net Profit Margin---2.438-1.501-38%-2.057-16%-4.894+101%-5.612+130%
Operating Margin---2.782-3.367+21%-2.721-2%-11.023+296%-8.109+191%
Operating Ratio--3.7823.562+6%3.608+5%9.458-60%8.063-53%
Pb Ratio0.197-61%0.3170.352-10%0.033+868%0.667-53%1.424-78%
Pe Ratio-0.220+38%-0.3530.146-341%-0.055-84%-0.096-73%-0.248-30%
Price Per Share1.950-61%3.1304.458-30%0.800+291%3.104+1%3.125+0%
Price To Free Cash Flow Ratio-0.151+38%-0.243-0.377+56%-0.059-76%-0.488+101%-0.402+65%
Price To Total Gains Ratio-1.351+38%-2.169-2.010-7%-0.169-92%-0.351-84%-0.482-78%
Quick Ratio--4.8135.497-12%5.616-14%5.925-19%8.846-46%
Return On Assets---0.145-0.088-40%-0.114-21%-0.086-41%-0.112-22%
Return On Equity---0.222-0.143-36%-0.152-31%-0.191-14%-0.585+163%
Total Gains Per Share---1.443-2.235+55%4.354-133%45.049-103%22.865-106%
Usd Book Value--12703000.00015630750.000-19%25732250.000-51%21765300.000-42%18752300.000-32%
Usd Book Value Change Per Share---1.443-2.235+55%4.354-133%0.360-501%0.511-382%
Usd Book Value Per Share--9.88312.324-20%23.175-57%15.995-38%14.543-32%
Usd Dividend Per Share----0%-0%44.689-100%22.353-100%
Usd Eps---2.220-2.988+35%-4.619+108%-2.970+34%-3.601+62%
Usd Free Cash Flow---4144999.000-3824749.750-8%-3512250.000-15%-5312499.950+28%-4541399.975+10%
Usd Free Cash Flow Per Share---3.225-3.001-7%-3.163-2%-3.804+18%-3.446+7%
Usd Free Cash Flow To Equity Per Share---3.22513.838-123%-1.128-65%2.567-226%1.614-300%
Usd Market Cap2165274.034-86%4023104.8105535569.765-27%888771.653+353%9232061.048-56%6686118.810-40%
Usd Price Per Share1.950-61%3.1304.458-30%0.800+291%3.104+1%3.125+0%
Usd Profit---2853000.000-2111750.000-26%-3864250.000+35%-3002950.000+5%-3629125.000+27%
Usd Revenue--1170000.0001416250.000-17%2489000.000-53%1594500.000-27%1324100.000-12%
Usd Total Gains Per Share---1.443-2.235+55%4.354-133%45.049-103%22.865-106%
 EOD+3 -5MRQTTM+12 -21YOY+8 -255Y+15 -2110Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Arcadia Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.220
Price to Book Ratio (EOD)Between0-10.197
Net Profit Margin (MRQ)Greater than0-2.438
Operating Margin (MRQ)Greater than0-2.782
Quick Ratio (MRQ)Greater than14.813
Current Ratio (MRQ)Greater than14.170
Debt to Asset Ratio (MRQ)Less than10.355
Debt to Equity Ratio (MRQ)Less than10.545
Return on Equity (MRQ)Greater than0.15-0.222
Return on Assets (MRQ)Greater than0.05-0.145
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Arcadia Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.923
Ma 20Greater thanMa 502.093
Ma 50Greater thanMa 1002.431
Ma 100Greater thanMa 2002.611
OpenGreater thanClose2.040
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets19,705
Total Liabilities7,002
Total Stockholder Equity12,841
 As reported
Total Liabilities 7,002
Total Stockholder Equity+ 12,841
Total Assets = 19,705

Assets

Total Assets19,705
Total Current Assets14,972
Long-term Assets4,733
Total Current Assets
Cash And Cash Equivalents 6,518
Short-term Investments 5,124
Net Receivables 514
Inventory 1,958
Other Current Assets 858
Total Current Assets  (as reported)14,972
Total Current Assets  (calculated)14,972
+/-0
Long-term Assets
Property Plant Equipment 1,176
Intangible Assets 39
Long-term Assets Other 3,518
Long-term Assets  (as reported)4,733
Long-term Assets  (calculated)4,733
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,590
Long-term Liabilities3,412
Total Stockholder Equity12,841
Total Current Liabilities
Short-term Debt 852
Accounts payable 2,410
Other Current Liabilities 328
Total Current Liabilities  (as reported)3,590
Total Current Liabilities  (calculated)3,590
+/-0
Long-term Liabilities
Capital Lease Obligations 1,007
Long-term Liabilities Other 2,000
Long-term Liabilities  (as reported)3,412
Long-term Liabilities  (calculated)3,007
+/- 405
Total Stockholder Equity
Common Stock65
Retained Earnings -271,840
Accumulated Other Comprehensive Income 101
Other Stockholders Equity 284,515
Total Stockholder Equity (as reported)12,841
Total Stockholder Equity (calculated)12,841
+/-0
Other
Capital Stock65
Cash and Short Term Investments 11,642
Common Stock Shares Outstanding 1,285
Liabilities and Stockholders Equity 19,705
Net Debt -5,511
Net Invested Capital 12,841
Net Working Capital 11,382
Property Plant and Equipment Gross 3,685
Short Long Term Debt Total 1,007



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
> Total Assets 
13,359
0
9,542
0
32,850
26,468
24,889
19,420
84,988
79,973
74,242
70,105
65,709
61,586
56,574
52,648
48,433
18,978
16,570
22,599
31,132
27,217
24,024
24,024
25,346
37,302
32,574
32,248
37,778
33,877
47,348
70,800
70,798
59,228
43,918
38,799
35,008
34,474
28,922
30,410
26,798
23,466
19,705
19,70523,46626,79830,41028,92234,47435,00838,79943,91859,22870,79870,80047,34833,87737,77832,24832,57437,30225,34624,02424,02427,21731,13222,59916,57018,97848,43352,64856,57461,58665,70970,10574,24279,97384,98819,42024,88926,46832,85009,542013,359
   > Total Current Assets 
0
0
4,567
0
27,690
22,986
18,695
12,373
81,636
76,642
52,017
52,535
56,197
55,675
52,222
50,444
46,517
17,166
15,047
21,245
29,966
26,203
22,876
22,876
22,000
33,606
28,440
23,758
26,096
21,194
31,696
56,613
50,916
43,834
35,388
31,499
30,058
30,031
25,398
27,205
23,339
20,006
14,972
14,97220,00623,33927,20525,39830,03130,05831,49935,38843,83450,91656,61331,69621,19426,09623,75828,44033,60622,00022,87622,87626,20329,96621,24515,04717,16646,51750,44452,22255,67556,19752,53552,01776,64281,63612,37318,69522,98627,69004,56700
       Cash And Cash Equivalents 
5,350
0
2,835
0
25,680
21,170
16,571
11,278
80,003
62,966
23,973
29,540
27,360
10,473
2,013
7,559
13,438
2,930
9,125
20,418
9,667
6,669
11,998
11,998
14,646
20,541
8,417
12,973
14,995
10,201
14,042
32,848
43,977
35,526
28,685
24,551
21,234
22,719
20,644
22,998
13,484
10,611
6,518
6,51810,61113,48422,99820,64422,71921,23424,55128,68535,52643,97732,84814,04210,20114,99512,9738,41720,54114,64611,99811,9986,6699,66720,4189,1252,93013,4387,5592,01310,47327,36029,54023,97362,96680,00311,27816,57121,17025,68002,83505,350
       Short-term Investments 
0
0
0
0
0
0
0
0
0
11,290
26,270
20,654
26,872
43,413
48,547
40,966
30,740
12,767
3,898
3,898
18,931
17,931
9,825
9,825
5,381
10,355
16,915
3,045
600
0
11,625
19,088
0
0
0
0
0
0
0
0
5,023
5,089
5,124
5,1245,0895,0230000000019,08811,62506003,04516,91510,3555,3819,8259,82517,93118,9313,8983,89812,76730,74040,96648,54743,41326,87220,65426,27011,290000000000
       Net Receivables 
0
0
1,024
0
890
1,154
1,422
320
357
1,116
788
693
269
241
533
396
573
134
1,235
101
286
361
168
168
125
127
602
309
403
373
1,406
1,113
1,147
1,453
1,370
2,768
3,854
2,726
1,287
923
630
304
514
5143046309231,2872,7263,8542,7681,3701,4531,1471,1131,4063734033096021271251681683612861011,2351345733965332412696937881,1163573201,4221,15489001,02400
       Other Current Assets 
398
0
258
0
210
219
278
254
704
672
692
1,332
1,390
1,188
877
1,281
1,480
1,099
560
417
800
888
704
704
1,009
740
712
1,460
1,326
1,204
811
901
1,895
1,408
900
691
1,441
990
809
606
951
1,093
858
8581,0939516068099901,4416919001,4081,8959018111,2041,3261,4607127401,0097047048888004175601,0991,4801,2818771,1881,3901,33269267270425427821921002580398
   > Long-term Assets 
0
0
4,975
0
5,160
3,482
6,194
7,047
3,352
3,331
22,225
17,570
9,512
5,911
4,352
2,204
1,916
1,812
1,523
1,354
1,166
1,014
1,148
1,148
3,346
3,696
4,134
8,490
11,682
12,683
15,652
14,187
19,882
15,394
8,530
7,300
4,950
4,443
3,524
3,205
3,459
3,460
4,733
4,7333,4603,4593,2053,5244,4434,9507,3008,53015,39419,88214,18715,65212,68311,6828,4904,1343,6963,3461,1481,1481,0141,1661,3541,5231,8121,9162,2044,3525,9119,51217,57022,2253,3313,3527,0476,1943,4825,16004,97500
       Property Plant Equipment 
1,125
0
941
0
760
700
728
663
633
597
585
656
636
580
508
486
417
369
299
280
270
265
1,141
395
2,690
3,194
3,762
8,194
9,001
9,497
9,365
9,116
10,100
6,120
5,372
4,014
3,262
2,921
2,552
2,240
1,944
1,615
1,176
1,1761,6151,9442,2402,5522,9213,2624,0145,3726,12010,1009,1169,3659,4979,0018,1943,7623,1942,6903951,141265270280299369417486508580636656585597633663728700760094101,125
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
301
408
408
1,648
1,648
0
0
0
0
0
0
0
0
0
0000000001,6481,64840840830100000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
500
500
500
500
19,748
14,907
6,910
3,479
2,498
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000002,4983,4796,91014,90719,748500500500500000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
370
350
4,068
3,905
484
471
386
373
40
40
40
40
39
39404040403733864714843,9054,06835037040000000000000000000000000000000
       Long-term Assets Other 
0
0
2,602
0
2,950
2,282
4,966
5,884
2,219
2,234
1,892
2,007
1,966
1,852
1,346
1,718
1,499
1,443
1,224
1,074
896
749
753
753
656
502
372
296
2,681
2,485
5,509
4,313
4,066
3,721
2,674
2,815
1,302
1,149
932
925
1,475
1,805
3,518
3,5181,8051,4759259321,1491,3022,8152,6743,7214,0664,3135,5092,4852,6812963725026567537537498961,0741,2241,4431,4991,7181,3461,8521,9662,0071,8922,2342,2195,8844,9662,2822,95002,60200
> Total Liabilities 
0
0
26,839
0
26,090
26,759
26,774
26,719
37,062
36,140
34,017
34,628
34,421
34,075
34,376
34,277
33,672
8,311
8,563
21,932
23,002
14,295
11,209
11,209
17,060
23,069
24,248
20,025
24,162
21,875
18,796
25,097
28,119
19,005
12,722
8,557
8,240
9,455
8,022
13,718
9,068
8,068
7,002
7,0028,0689,06813,7188,0229,4558,2408,55712,72219,00528,11925,09718,79621,87524,16220,02524,24823,06917,06011,20911,20914,29523,00221,9328,5638,31133,67234,27734,37634,07534,42134,62834,01736,14037,06226,71926,77426,75926,090026,83900
   > Total Current Liabilities 
3,356
0
9,544
0
9,520
10,770
11,269
12,056
11,783
10,895
3,450
4,158
4,079
3,825
3,129
5,171
6,694
2,520
3,525
3,032
2,923
2,637
3,054
3,054
4,157
6,023
5,708
5,808
8,364
8,408
6,314
5,617
7,651
6,489
5,040
4,809
4,740
4,051
4,209
4,097
4,091
3,885
3,590
3,5903,8854,0914,0974,2094,0514,7404,8095,0406,4897,6515,6176,3148,4088,3645,8085,7086,0234,1573,0543,0542,6372,9233,0323,5252,5206,6945,1713,1293,8254,0794,1583,45010,89511,78312,05611,26910,7709,52009,54403,356
       Short-term Debt 
0
0
4,640
0
4,860
5,406
5,606
4,363
3,456
3,639
-1,999
0
0
0
25,127
2,083
4,167
0
0
0
0
0
0
2,389
594
633
635
557
1,142
1,405
1,858
1,846
2,102
1,170
1,074
1,036
994
986
1,010
1,014
993
924
852
8529249931,0141,0109869941,0361,0741,1702,1021,8461,8581,4051,1425576356335942,3890000004,1672,08325,127000-1,9993,6393,4564,3635,6065,4064,86004,64000
       Short Long Term Debt 
0
0
0
0
0
0
1,055
0
0
0
24,930
0
0
0
25,127
2,083
25,225
0
0
0
0
0
0
574
0
24
24
31
519
705
1,141
1,141
1,140
36
0
0
0
0
0
0
0
0
0
000000000361,1401,1411,141705519312424057400000025,2252,08325,12700024,9300001,055000000
       Accounts payable 
137
0
220
0
560
137
244
3,381
4,677
3,976
2,423
2,792
2,570
2,610
222
2,183
1,834
1,863
366
2,457
2,441
2,303
2,674
285
3,265
5,016
492
4,912
6,937
6,711
4,105
3,418
5,189
5,004
3,638
3,440
3,391
2,748
931
2,785
2,783
2,602
2,410
2,4102,6022,7832,7859312,7483,3913,4403,6385,0045,1893,4184,1056,7116,9374,9124925,0163,2652852,6742,3032,4412,4573661,8631,8342,1832222,6102,5702,7922,4233,9764,6773,38124413756002200137
       Other Current Liabilities 
3,219
0
3,610
0
4,100
4,083
4,589
3,057
2,698
2,440
2,018
13
15
19
2,167
20
27
31
2,159
4
12
18
380
284
283
294
4,539
322
263
263
343
290
297
264
264
333
355
317
2,268
298
282
313
328
3283132822982,2683173553332642642972903432632633224,539294283284380181242,1593127202,1671915132,0182,4402,6983,0574,5894,0834,10003,61003,219
   > Long-term Liabilities 
0
0
17,295
0
16,570
15,989
15,505
14,663
25,279
25,245
30,567
30,470
30,342
30,250
31,247
29,106
26,978
5,791
5,038
18,900
20,079
11,658
8,155
8,155
12,903
17,046
18,540
14,217
15,798
13,467
12,482
19,480
20,468
12,516
7,682
3,748
3,500
5,404
3,813
9,621
4,977
4,183
3,412
3,4124,1834,9779,6213,8135,4043,5003,7487,68212,51620,46819,48012,48213,46715,79814,21718,54017,04612,9038,1558,15511,65820,07918,9005,0385,79126,97829,10631,24730,25030,34230,47030,56725,24525,27914,66315,50515,98916,570017,29500
       Long term Debt Total 
0
0
0
0
0
0
0
588
19,349
19,462
24,930
24,978
25,027
25,077
25,127
23,092
21,058
0
0
0
0
0
0
0
0
113
107
130
2,742
2,548
2,105
96
87
0
0
0
0
0
0
0
0
0
0
000000000087962,1052,5482,7421301071130000000021,05823,09225,12725,07725,02724,97824,93019,46219,3495880000000
       Capital Lease Obligations Min Short Term Debt
0
0
-4,640
0
-4,860
-5,406
-5,606
-4,363
-3,456
-3,639
1,999
0
0
0
-25,127
-2,083
-4,167
0
0
0
0
0
0
-44
1,609
1,426
1,473
5,281
4,701
4,869
4,248
4,087
4,587
2,526
2,220
1,709
1,500
1,269
1,007
760
532
347
155
1553475327601,0071,2691,5001,7092,2202,5264,5874,0874,2484,8694,7015,2811,4731,4261,609-44000000-4,167-2,083-25,1270001,999-3,639-3,456-4,363-5,606-5,406-4,8600-4,64000
       Warrants
0
0
0
0
0
0
0
84,576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000084,5760000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
11,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
18,900
20,079
11,658
8,155
18,349
3,000
16,933
18,433
14,087
2,000
10,919
2,280
19,384
2,140
2,140
2,070
2,039
2,000
2,000
2,000
2,000
2,000
2,000
2,000
2,0002,0002,0002,0002,0002,0002,0002,0392,0702,1402,14019,3842,28010,9192,00014,08718,43316,9333,00018,3498,15511,65820,07918,9003,0003,0003,0003,0003,0003,0003,0003,0003,0003,0003,00011,0000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
2,800
3,075
2,930
2,783
2,637
2,492
2,315
2,173
3,120
3,014
2,920
2,791
2,038
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000002,0382,7912,9203,0143,1202,1732,3152,4922,6372,7832,9303,0752,800000000
> Total Stockholder Equity
0
0
-17,297
0
6,750
-291
-1,885
-7,299
47,926
43,833
40,225
35,477
31,288
27,511
22,198
18,371
14,761
10,667
8,007
667
8,130
12,922
12,815
12,815
8,286
13,544
7,705
11,015
12,120
11,280
27,725
44,503
41,640
39,845
31,093
30,261
26,807
25,068
21,033
16,825
17,868
15,536
12,841
12,84115,53617,86816,82521,03325,06826,80730,26131,09339,84541,64044,50327,72511,28012,12011,0157,70513,5448,28612,81512,81512,9228,1306678,00710,66714,76118,37122,19827,51131,28835,47740,22543,83347,926-7,299-1,885-2916,7500-17,29700
   Common Stock
0
0
0
0
0
0
0
0
44
44
44
44
44
44
44
43
43
43
42
43
45
45
45
45
47
49
49
49
50
51
54
62
63
63
63
63
63
65
65
65
65
65
65
656565656565636363636362545150494949474545454543424343434444444444444400000000
   Retained Earnings Total Equity0000000000-215,027-209,767-211,825-220,725-214,335-204,646-207,171-200,928-186,741-190,978-178,366-177,720-182,170-175,501-167,257-164,297-159,772-155,766-151,550-145,842-141,667-137,116-131,926-128,069-123,450-119,7730000000
   Accumulated Other Comprehensive Income 
0
0
-4,330
0
-4,490
-4,583
-4,655
0
-84,988
-79,973
-115
-31
-6
-7
-19
-20
-13
-4
-1
-4,881
0
-2
-4,801
-4,801
0
0
1
-4,643
0
0
0
-5,123
-12
-24
0
0
0
0
0
0
21
87
101
1018721000000-24-12-5,123000-4,643100-4,801-4,801-20-4,881-1-4-13-20-19-7-6-31-115-79,973-84,9880-4,655-4,583-4,4900-4,33000
   Capital Surplus 
0
0
0
0
0
0
0
27,898
171,332
171,858
172,222
172,580
172,917
173,316
173,723
174,114
174,503
174,925
175,223
176,125
190,255
190,599
191,136
191,566
194,980
214,423
214,826
215,612
226,405
231,954
239,496
254,208
256,616
0
0
0
0
0
0
0
0
0
0
0000000000256,616254,208239,496231,954226,405215,612214,826214,423194,980191,566191,136190,599190,255176,125175,223174,925174,503174,114173,723173,316172,917172,580172,222171,858171,33227,8980000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
82,664
0
116,160
35,043
116,740
27,898
171,332
171,858
176,766
172,549
172,911
173,309
178,645
174,094
174,490
174,921
180,103
176,125
190,255
190,597
0
195,937
194,980
214,423
219,470
215,612
226,405
231,954
239,496
259,331
256,616
249,651
257,515
277,169
277,492
278,618
278,827
284,003
284,202
282,535
284,515
284,515282,535284,202284,003278,827278,618277,492277,169257,515249,651256,616259,331239,496231,954226,405215,612219,470214,423194,980195,9370190,597190,255176,125180,103174,921174,490174,094178,645173,309172,911172,549176,766171,858171,33227,898116,74035,043116,160082,66400



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,330
Cost of Revenue-3,300
Gross Profit2,0302,030
 
Operating Income (+$)
Gross Profit2,030
Operating Expense-15,895
Operating Income-13,865-13,865
 
Operating Expense (+$)
Research Development1,387
Selling General Administrative17,726
Selling And Marketing Expenses0
Operating Expense15,89519,113
 
Net Interest Income (+$)
Interest Income695
Interest Expense-0
Other Finance Cost-9
Net Interest Income704
 
Pretax Income (+$)
Operating Income-13,865
Net Interest Income704
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-13,157-14,573
EBIT - interestExpense = -13,865
-13,973
-13,981
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-13,865-13,157
Earnings Before Interest and Taxes (EBITDA)-12,881
 
After tax Income (+$)
Income Before Tax-13,157
Tax Provision-14
Net Income From Continuing Ops-18,506-13,171
Net Income-13,981
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses19,195
Total Other Income/Expenses Net708-704
 

Technical Analysis of Arcadia Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Arcadia Biosciences Inc. The general trend of Arcadia Biosciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Arcadia Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Arcadia Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.995 < 2.33 < 2.34.

The bearish price targets are: .

Tweet this
Arcadia Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Arcadia Biosciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Arcadia Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Arcadia Biosciences Inc. The current macd is -0.13877278.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Arcadia Biosciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Arcadia Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Arcadia Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Arcadia Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartArcadia Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Arcadia Biosciences Inc. The current adx is 32.31.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Arcadia Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Arcadia Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Arcadia Biosciences Inc. The current sar is 2.19.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Arcadia Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Arcadia Biosciences Inc. The current rsi is 35.92. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Arcadia Biosciences Inc Daily Relative Strength Index (RSI) ChartArcadia Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Arcadia Biosciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Arcadia Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Arcadia Biosciences Inc Daily Stochastic Oscillator ChartArcadia Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Arcadia Biosciences Inc. The current cci is -75.57442102.

Arcadia Biosciences Inc Daily Commodity Channel Index (CCI) ChartArcadia Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Arcadia Biosciences Inc. The current cmo is -26.40884414.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Arcadia Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartArcadia Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Arcadia Biosciences Inc. The current willr is -73.95997894.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Arcadia Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Arcadia Biosciences Inc Daily Williams %R ChartArcadia Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Arcadia Biosciences Inc.

Arcadia Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Arcadia Biosciences Inc. The current atr is 0.14200923.

Arcadia Biosciences Inc Daily Average True Range (ATR) ChartArcadia Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Arcadia Biosciences Inc. The current obv is 8,472,505.

Arcadia Biosciences Inc Daily On-Balance Volume (OBV) ChartArcadia Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Arcadia Biosciences Inc. The current mfi is 46.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Arcadia Biosciences Inc Daily Money Flow Index (MFI) ChartArcadia Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Arcadia Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Arcadia Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Arcadia Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.923
Ma 20Greater thanMa 502.093
Ma 50Greater thanMa 1002.431
Ma 100Greater thanMa 2002.611
OpenGreater thanClose2.040
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Arcadia Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Arcadia Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Arcadia Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Arcadia Biosciences Inc

I send you an email if I find something interesting about Arcadia Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Arcadia Biosciences Inc.

Receive notifications about Arcadia Biosciences Inc in your mailbox!